Ads
related to: alcon rocklatan coupon- Tolerability Data
Explore The Tolerability Data From
VYZULTA Phase 3 Trials.
- Appropriate Patient Types
View The Appropriate Patient Types
That May Benefit From VYZULTA.
- Real World Studies
View Real World Studies Data To See
How VYZULTA May Help Your Patients.
- Dosing Information
Learn How This Treatment's
Dosing May Help Your Patients.
- Tolerability Data
goodrx.com has been visited by 1M+ users in the past month
Search results
Results From The WOW.Com Content Network
KEGG. D11558. Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. [1][2] It contains netarsudil mesylate and latanoprost. [1][2] It is applied as eye drops to the eyes. [1][2 ...
Latanoprost. Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye (intraocular pressure). [5] This includes ocular hypertension and open-angle glaucoma. [5] Latanaprost is applied as eye drops to the eyes. [5]
Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva , Switzerland but its operational headquarters are in Fort Worth, Texas , United States , where it employs about 4,500 people.
Founded in 1945 and based in Switzerland, Alcon AG (ALC) is a global provider of ophthalmic surgery and vision care products; previously a subsidiary of Novartis AG (NVS), Alcon became an ...
Alcon AG (NYSE: ALC) has agreed to acquire Aerie Pharmaceuticals Inc (NASDAQ: AERI) for $15.25 per share, valuing Aerie at about $770 million. ... The deal will add Aerie's Rocklatan and Rhopressa ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Ads
related to: alcon rocklatan coupongoodrx.com has been visited by 1M+ users in the past month